Human pancreatic growth hormone releasing factor [GRF(1-44)] is the largest molecule of several peptides recently isolated from pancreatic tumours associated with acromegaly. It has been shown to stimulate the release of growth hormone in normal subjects and provides a safe and reliable tool for exa
Plasma growth hormone-releasing hormone levels in type 1 (insulin-dependent) diabetic children following a mixed meal
β Scribed by Rosskamp, R. ;Haverkamp, F. ;Thomas, B. ;Klumpp, J.
- Publisher
- Springer-Verlag
- Year
- 1988
- Tongue
- English
- Weight
- 435 KB
- Volume
- 66
- Category
- Article
- ISSN
- 1432-1440
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Serum levels of insulin-like growth factor I are reduced in patients with Type 1 (insulin-dependent) diabetes mellitus. To evaluate the role of the hepatic growth hormone receptor in the decreased serum concentrations of insulinlike growth factor I, serum levels of the high affinity growth hormone-b
In order to reassess the role of growth hormone in the dawn phenomenon, we studied eight C-peptide negative diabetic adolescents, who are likely to exhibit important nocturnal growth hormone surges. The insulin infusion rate necessary to maintain euglycaemia was predetermined in each patient from 22
Previous studies have suggested that nerve regeneration may be defective in patients with diabetic polyneuropathy. Since insulin-like growth factor I (IGF-I) has been shown to stimulate nerve regeneration, and IGF binding protein-1 is acutely regulated by plasma insulin we have investigated the rela